- IBDEI3BS ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4,2015,0)
- ;;=VARICOSE VEINS^50^152
- ;;^UTILITY(U,$J,358.4,2016,0)
- ;;=WOMEN'S HEALTH^51^152
- ;;^UTILITY(U,$J,358.4,2017,0)
- ;;=WOUNDS-INITIAL ENCOUNTER^52^152
- ;;^UTILITY(U,$J,358.4,2018,0)
- ;;=COMA^20^152
- ;;^UTILITY(U,$J,358.4,2019,0)
- ;;=CAUSES OF INJURY^19^152
- ;;^UTILITY(U,$J,358.4,2020,0)
- ;;=DEMENTIA^21^152
- ;;^UTILITY(U,$J,358.4,2021,0)
- ;;=LONG TERM CURRENT DRUG THERAPY^37^152
- ;;^UTILITY(U,$J,358.4,2022,0)
- ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^152
- ;;^UTILITY(U,$J,358.4,2023,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^49^152
- ;;^UTILITY(U,$J,358.4,2024,0)
- ;;=ACSC ACUTE KIDNEY FAILURE^3^152
- ;;^UTILITY(U,$J,358.4,2025,0)
- ;;=ACSC ANGINA^4^152
- ;;^UTILITY(U,$J,358.4,2026,0)
- ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^152
- ;;^UTILITY(U,$J,358.4,2027,0)
- ;;=ACSC CHF^6^152
- ;;^UTILITY(U,$J,358.4,2028,0)
- ;;=ACSC DEHYDRATION^7^152
- ;;^UTILITY(U,$J,358.4,2029,0)
- ;;=ACSC DIABETES TYPE 1^8^152
- ;;^UTILITY(U,$J,358.4,2030,0)
- ;;=ACSC DIABETES TYPE 2^9^152
- ;;^UTILITY(U,$J,358.4,2031,0)
- ;;=ACSC HYPERTENSION^10^152
- ;;^UTILITY(U,$J,358.4,2032,0)
- ;;=ACSC INFECTIOUS GASTROENTERITIS^11^152
- ;;^UTILITY(U,$J,358.4,2033,0)
- ;;=ACSC PNEUMONIA^12^152
- ;;^UTILITY(U,$J,358.4,2034,0)
- ;;=ACSC UTI^13^152
- ;;^UTILITY(U,$J,358.4,2035,0)
- ;;=ACSC VIRAL ENTERITIS^14^152
- ;;^UTILITY(U,$J,358.4,2036,0)
- ;;=E-CIG/VAPE LUNG INJURY^23^152
- ;;^UTILITY(U,$J,358.4,2037,0)
- ;;=NEW PATIENT^2^153
- ;;^UTILITY(U,$J,358.4,2038,0)
- ;;=ESTABLISHED PATIENT^1^153
- ;;^UTILITY(U,$J,358.4,2039,0)
- ;;=CONSULTATIONS^3^153
- ;;^UTILITY(U,$J,358.4,2040,0)
- ;;=THERAPY MODALITIES/PROCEDURES^19^154
- ;;^UTILITY(U,$J,358.4,2041,0)
- ;;=DRUGS/MEDICATION^6^154
- ;;^UTILITY(U,$J,358.4,2042,0)
- ;;=ORTHOTIC DEVICES^13^154
- ;;^UTILITY(U,$J,358.4,2043,0)
- ;;=KINESIOTHERAPY^11^154
- ;;^UTILITY(U,$J,358.4,2044,0)
- ;;=THERAPY EVALUATIONS^18^154
- ;;^UTILITY(U,$J,358.4,2045,0)
- ;;=WOUND CARE^20^154
- ;;^UTILITY(U,$J,358.4,2046,0)
- ;;=CARDIAC REHAB^4^154
- ;;^UTILITY(U,$J,358.4,2047,0)
- ;;=EDUCATION/TRAINING^7^154
- ;;^UTILITY(U,$J,358.4,2048,0)
- ;;=HOME THERAPY SERVICES^9^154
- ;;^UTILITY(U,$J,358.4,2049,0)
- ;;=NEUROMUSCULAR TESTING^12^154
- ;;^UTILITY(U,$J,358.4,2050,0)
- ;;=TEAM CONFERENCE^16^154
- ;;^UTILITY(U,$J,358.4,2051,0)
- ;;=HEALTH BEHAVIORS^8^154
- ;;^UTILITY(U,$J,358.4,2052,0)
- ;;=RECREATION THERAPY^14^154
- ;;^UTILITY(U,$J,358.4,2053,0)
- ;;=DEVICES/SUPPLIES^5^154
- ;;^UTILITY(U,$J,358.4,2054,0)
- ;;=TENS^17^154
- ;;^UTILITY(U,$J,358.4,2055,0)
- ;;=ACUPUNCTURE^1^154
- ;;^UTILITY(U,$J,358.4,2056,0)
- ;;=INJECTIONS^10^154
- ;;^UTILITY(U,$J,358.4,2057,0)
- ;;=SPINAL CORD STIMULATOR^15^154
- ;;^UTILITY(U,$J,358.4,2058,0)
- ;;=ADAPTIVE BEHAVIOR ASSESSMENTS^2^154
- ;;^UTILITY(U,$J,358.4,2059,0)
- ;;=ADAPTIVE BEHAVIOR TREATMENT^3^154
- ;;^UTILITY(U,$J,358.4,2060,0)
- ;;=AMPUTATION STATUS^1^155
- ;;^UTILITY(U,$J,358.4,2061,0)
- ;;=BRAIN DISORDERS^2^155
- ;;^UTILITY(U,$J,358.4,2062,0)
- ;;=CARDIOPULMONARY^4^155
- ;;^UTILITY(U,$J,358.4,2063,0)
- ;;=COMPLICATIONS DUE TO^5^155
- ;;^UTILITY(U,$J,358.4,2064,0)
- ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^12^155
- ;;^UTILITY(U,$J,358.4,2065,0)
- ;;=Z CODES^21^155
- ;;^UTILITY(U,$J,358.4,2066,0)
- ;;=BRAIN INJURY - TRAUMATIC^3^155
- ;;^UTILITY(U,$J,358.4,2067,0)
- ;;=FEMUR/THIGH/KNEE FRACTURE^7^155
- ;;^UTILITY(U,$J,358.4,2068,0)
- ;;=FOOT/TOE/ANKLE FRANCTURE^8^155
- ;;^UTILITY(U,$J,358.4,2069,0)
- ;;=HAND/FINGER FRACTURE^9^155
- ;;^UTILITY(U,$J,358.4,2070,0)
- ;;=HIP/PELVIS FRACTURE^10^155
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3BS 3762 printed Mar 13, 2025@21:50:33 Page 2
- IBDEI3BS ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4,2015,0)
- +2 ;;=VARICOSE VEINS^50^152
- +3 ;;^UTILITY(U,$J,358.4,2016,0)
- +4 ;;=WOMEN'S HEALTH^51^152
- +5 ;;^UTILITY(U,$J,358.4,2017,0)
- +6 ;;=WOUNDS-INITIAL ENCOUNTER^52^152
- +7 ;;^UTILITY(U,$J,358.4,2018,0)
- +8 ;;=COMA^20^152
- +9 ;;^UTILITY(U,$J,358.4,2019,0)
- +10 ;;=CAUSES OF INJURY^19^152
- +11 ;;^UTILITY(U,$J,358.4,2020,0)
- +12 ;;=DEMENTIA^21^152
- +13 ;;^UTILITY(U,$J,358.4,2021,0)
- +14 ;;=LONG TERM CURRENT DRUG THERAPY^37^152
- +15 ;;^UTILITY(U,$J,358.4,2022,0)
- +16 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^152
- +17 ;;^UTILITY(U,$J,358.4,2023,0)
- +18 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^152
- +19 ;;^UTILITY(U,$J,358.4,2024,0)
- +20 ;;=ACSC ACUTE KIDNEY FAILURE^3^152
- +21 ;;^UTILITY(U,$J,358.4,2025,0)
- +22 ;;=ACSC ANGINA^4^152
- +23 ;;^UTILITY(U,$J,358.4,2026,0)
- +24 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^152
- +25 ;;^UTILITY(U,$J,358.4,2027,0)
- +26 ;;=ACSC CHF^6^152
- +27 ;;^UTILITY(U,$J,358.4,2028,0)
- +28 ;;=ACSC DEHYDRATION^7^152
- +29 ;;^UTILITY(U,$J,358.4,2029,0)
- +30 ;;=ACSC DIABETES TYPE 1^8^152
- +31 ;;^UTILITY(U,$J,358.4,2030,0)
- +32 ;;=ACSC DIABETES TYPE 2^9^152
- +33 ;;^UTILITY(U,$J,358.4,2031,0)
- +34 ;;=ACSC HYPERTENSION^10^152
- +35 ;;^UTILITY(U,$J,358.4,2032,0)
- +36 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^152
- +37 ;;^UTILITY(U,$J,358.4,2033,0)
- +38 ;;=ACSC PNEUMONIA^12^152
- +39 ;;^UTILITY(U,$J,358.4,2034,0)
- +40 ;;=ACSC UTI^13^152
- +41 ;;^UTILITY(U,$J,358.4,2035,0)
- +42 ;;=ACSC VIRAL ENTERITIS^14^152
- +43 ;;^UTILITY(U,$J,358.4,2036,0)
- +44 ;;=E-CIG/VAPE LUNG INJURY^23^152
- +45 ;;^UTILITY(U,$J,358.4,2037,0)
- +46 ;;=NEW PATIENT^2^153
- +47 ;;^UTILITY(U,$J,358.4,2038,0)
- +48 ;;=ESTABLISHED PATIENT^1^153
- +49 ;;^UTILITY(U,$J,358.4,2039,0)
- +50 ;;=CONSULTATIONS^3^153
- +51 ;;^UTILITY(U,$J,358.4,2040,0)
- +52 ;;=THERAPY MODALITIES/PROCEDURES^19^154
- +53 ;;^UTILITY(U,$J,358.4,2041,0)
- +54 ;;=DRUGS/MEDICATION^6^154
- +55 ;;^UTILITY(U,$J,358.4,2042,0)
- +56 ;;=ORTHOTIC DEVICES^13^154
- +57 ;;^UTILITY(U,$J,358.4,2043,0)
- +58 ;;=KINESIOTHERAPY^11^154
- +59 ;;^UTILITY(U,$J,358.4,2044,0)
- +60 ;;=THERAPY EVALUATIONS^18^154
- +61 ;;^UTILITY(U,$J,358.4,2045,0)
- +62 ;;=WOUND CARE^20^154
- +63 ;;^UTILITY(U,$J,358.4,2046,0)
- +64 ;;=CARDIAC REHAB^4^154
- +65 ;;^UTILITY(U,$J,358.4,2047,0)
- +66 ;;=EDUCATION/TRAINING^7^154
- +67 ;;^UTILITY(U,$J,358.4,2048,0)
- +68 ;;=HOME THERAPY SERVICES^9^154
- +69 ;;^UTILITY(U,$J,358.4,2049,0)
- +70 ;;=NEUROMUSCULAR TESTING^12^154
- +71 ;;^UTILITY(U,$J,358.4,2050,0)
- +72 ;;=TEAM CONFERENCE^16^154
- +73 ;;^UTILITY(U,$J,358.4,2051,0)
- +74 ;;=HEALTH BEHAVIORS^8^154
- +75 ;;^UTILITY(U,$J,358.4,2052,0)
- +76 ;;=RECREATION THERAPY^14^154
- +77 ;;^UTILITY(U,$J,358.4,2053,0)
- +78 ;;=DEVICES/SUPPLIES^5^154
- +79 ;;^UTILITY(U,$J,358.4,2054,0)
- +80 ;;=TENS^17^154
- +81 ;;^UTILITY(U,$J,358.4,2055,0)
- +82 ;;=ACUPUNCTURE^1^154
- +83 ;;^UTILITY(U,$J,358.4,2056,0)
- +84 ;;=INJECTIONS^10^154
- +85 ;;^UTILITY(U,$J,358.4,2057,0)
- +86 ;;=SPINAL CORD STIMULATOR^15^154
- +87 ;;^UTILITY(U,$J,358.4,2058,0)
- +88 ;;=ADAPTIVE BEHAVIOR ASSESSMENTS^2^154
- +89 ;;^UTILITY(U,$J,358.4,2059,0)
- +90 ;;=ADAPTIVE BEHAVIOR TREATMENT^3^154
- +91 ;;^UTILITY(U,$J,358.4,2060,0)
- +92 ;;=AMPUTATION STATUS^1^155
- +93 ;;^UTILITY(U,$J,358.4,2061,0)
- +94 ;;=BRAIN DISORDERS^2^155
- +95 ;;^UTILITY(U,$J,358.4,2062,0)
- +96 ;;=CARDIOPULMONARY^4^155
- +97 ;;^UTILITY(U,$J,358.4,2063,0)
- +98 ;;=COMPLICATIONS DUE TO^5^155
- +99 ;;^UTILITY(U,$J,358.4,2064,0)
- +100 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^12^155
- +101 ;;^UTILITY(U,$J,358.4,2065,0)
- +102 ;;=Z CODES^21^155
- +103 ;;^UTILITY(U,$J,358.4,2066,0)
- +104 ;;=BRAIN INJURY - TRAUMATIC^3^155
- +105 ;;^UTILITY(U,$J,358.4,2067,0)
- +106 ;;=FEMUR/THIGH/KNEE FRACTURE^7^155
- +107 ;;^UTILITY(U,$J,358.4,2068,0)
- +108 ;;=FOOT/TOE/ANKLE FRANCTURE^8^155
- +109 ;;^UTILITY(U,$J,358.4,2069,0)
- +110 ;;=HAND/FINGER FRACTURE^9^155
- +111 ;;^UTILITY(U,$J,358.4,2070,0)
- +112 ;;=HIP/PELVIS FRACTURE^10^155
